Explore the challenges faced by Indian pharma in developing rare disease drugs and potential solutions for innovation and cost reduction.
18hOpinion
‘Cool China’ is a serene, innovative force in today’s multipolar landscape: African expert
GT: Many foreign media outlets, when mentioning "cool China," often highlight one aspect: China's technological development.
Learn moreYou crave a good night's sleep after a long day — but your noisy neighbors, snoring partner, or early rising ...
SXSW Sydney ran from the 13th to 19th October 2025 at venues all across Gadigal.
The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback